Michael Mano serves as Executive at Karyopharm Therapeutics Inc., where they oversee executive responsibilities. Since joining the company, Michael Mano has executed 13 insider transactions totaling $54.5K, demonstrating a bearish approach to their equity position. Their most recent transaction on Oct 15, 2025 involved receiving (via award) 43,650 shares valued at $0.
Michael Mano currently holds 65,075 shares of Karyopharm Therapeutics Inc. (KPTI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael Mano has been a net seller of KPTI stock. They have purchased $0 and sold $54.5K worth of shares.
Michael Mano's most recent insider trade was on Oct 15, 2025, when they sold 43,650 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $6.43 |
| Discretionary |
| Sep 12, 2025 | KPTI | $0 | Award | 612 | $N/A | Discretionary |
| Sep 4, 2024 | KPTI | $2.9K | Sale | 3,971 | $0.72 | Discretionary |
| Mar 1, 2024 | KPTI | $4.3K | Sale | 3,576 | $1.20 | Discretionary |
| Feb 29, 2024 | KPTI | $19.9K | Sale | 16,973 | $1.17 | Discretionary |
| Feb 28, 2024 | KPTI | $0 | Award | 147,000 | $N/A | Discretionary |
| Jan 24, 2024 | KPTI | $0 | Award | 9,167 | $N/A | Discretionary |
| Sep 1, 2023 | KPTI | $5.2K | Sale | 3,888 | $1.33 | Discretionary |
| Mar 1, 2023 | KPTI | $20.8K | Sale | 6,878 | $3.03 | Discretionary |
| Feb 28, 2023 | KPTI | $0 | Award | 70,000 | $N/A | Discretionary |
| Aug 31, 2022 | KPTI | $0 | Award | 20,000 | $N/A | Discretionary |
| Feb 28, 2022 | KPTI | $0 | Award | 63,000 | $N/A | Discretionary |